Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial

Catherine Duda, Irene Mahon, Mei Hsiu Chen, Bradley Snyder, Richard Barrd, Caroline Chiles, Robert Falk, Elliot K. Fishman, David Gemmel, Jonathan G. Goldin, Kathleen Brown, Reginald F. Munden, Kay Vydareny, Denise R. Aberle

Research output: Contribution to journalArticlepeer-review

Abstract

Background: To promote results in the National Lung Screening Trial (NLST) that are generalizable across the entire US population, a subset of NLST sites developed dedicated strategies for minority recruitment. Purpose: To report the effects of targeted strategies on the accrual of underrepresented groups, to describe participant characteristics, and to estimate the costs of targeted enrollment. Methods: The 2002-2004 Tobacco Use Supplement was used to estimate eligible proportions of racial and ethnic categories. Strategic planning included meetings/conferences with key stakeholders and minority organizations. Potential institutions were selected based upon regional racial/ethnic diversity and proven success in recruitment of underrepresented groups. Seven institutions submitted targeted recruitment strategies with budgets. Accrual by racial/ethnic category was tracked for each institution. Cost estimates were based on itemized receipts for minority strategies relative to minority accrual. Results: Of 18,842 participants enrolled, 1576 (8.4%) were minority participants. The seven institutions with targeted recruitment strategies accounted for 1223 (77.6%) of all minority participants enrolled. While there was a significant increase in the rate of minority accrual pre-implementation to post-implementation for the institutions with targeted recruitment (9.3% vs. 15.2%, p<0.0001), there was no significant difference for the institutions without (3.5% vs. 3.8%, p=0.46). Minority enrollees at the seven institutions tended to have less than a high school education, be economically disadvantaged, and were more often uninsured. These socio-demographic differences persisted at the seven institutions even after adjusting for race and ethnicity. The success of different strategies varied by institution, and no one strategy was successful across all institutions. Costs for implementation were also highly variable, ranging from $146 to $749 per minority enrollee. Limitations: Data on minority recruitment processes were not consistently kept at the individual institutions. In addition, participant responses via newspaper advertisements and the efforts of minority staff hired by the institutions could not be coded on Case Report Forms. Conclusions: Strategic efforts were associated with significant increases in minority enrollment. The greatest successes require that a priori goals be established based on eligible racial/ethnic proportions; the historical performance of sites in minority accrual should factor into the selection of sites; recruitment planning must begin well in advance of trial launch; and there must be endorsement by prominent representatives of the racial groups of interest.

Original languageEnglish (US)
Pages (from-to)214-223
Number of pages10
JournalClinical Trials
Volume8
Issue number2
DOIs
StatePublished - Apr 2011

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial'. Together they form a unique fingerprint.

Cite this